Biotech Values

[midastouch017]

< don't understand why they don't add more staff to the generics division at the FDA>

Sheer favourism towards big Pharma, imo:
<"The branded industry has to be delighted by this backlog," said Jake Hansen, vice president for government affairs for Barr Laboratories Inc., a maker of generic drugs.>

A 'natural & given' situation, Israel probably acting in
a similar manner in its favourism towards TEVA.

I have made this claim long ago on the TEVA board and
Israel Healthcare board as well.

Dubi